Tandem Diabetes Care (TNDM) PT Lowered to $50 at Piper Sandler
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts TNDM Hot Sheet
Price: $19.79 +0.56%
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 27 | New: 16
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 27 | New: 16
Join SI Premium – FREE
Piper Sandler analyst Matt O'Brien lowered the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $50.00 (from $70.00) while maintaining a Overweight rating.
You May Also Be Interested In
- HSBC Upgrades FedEx (FDX) to Buy
- BlackRock (BLK) PT Raised to $1,400 at Freedom Broker
- Bausch Health Companies (BHC) PT Raised to $8 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
